<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Lagoda Investment Management, L.P. -->
          <cik>0001632108</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <dateOfEvent>09/15/2026</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0000093314</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>928661206</issuerCusipNumber>
        </issuerCusips>
        <issuerName>VolitionRx Limited</issuerName>
        <address>
          <com:street1>1489 West Warm Springs Road</com:street1>
          <com:street2>Suite 110</com:street2>
          <com:city>Henderson</com:city>
          <com:stateOrCountry>NV</com:stateOrCountry>
          <com:zipCode>89014</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Jason A. Ozone</personName>
          <personPhoneNum>(212) 309-7660</personPhoneNum>
          <personAddress>
            <com:street1>Lagoda Investment Management, L.P.</com:street1>
            <com:street2>3 Columbus Circle, Floor 15</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10019</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001632108</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Lagoda Investment Management, L.P.</reportingPersonName>
        <fundType>WC</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1650505.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1650505.00</sharedDispositivePower>
        <aggregateAmountOwned>1650505.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>5.9</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
        <commentContent>See Item 2 of the Schedule 13D for additional information.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Lagoda Investment Management, LLC</reportingPersonName>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1650505.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1650505.00</sharedDispositivePower>
        <aggregateAmountOwned>1650505.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>5.9</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <commentContent>See Item 2 of the Schedule 13D for additional information.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Fatima Dickey</reportingPersonName>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1650505.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1650505.00</sharedDispositivePower>
        <aggregateAmountOwned>1650505.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>5.9</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>See Item 2 of the Schedule 13D for additional information.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.001 per share</securityTitle>
        <issuerName>VolitionRx Limited</issuerName>
        <issuerPrincipalAddress>
          <com:street1>1489 West Warm Springs Road</com:street1>
          <com:street2>Suite 110</com:street2>
          <com:city>Henderson</com:city>
          <com:stateOrCountry>NV</com:stateOrCountry>
          <com:zipCode>89014</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment No. 1 to Schedule 13D (this "Amendment") amends and supplements the Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission on September 4, 2026 (the "Schedule 13D"). Capitalized terms used but not defined in this Amendment have the meanings given to them in the Schedule 13D. Except as specifically amended by this Amendment, the Schedule 13D remains unchanged.</commentText>
      </item1>
      <item2>
        <filingPersonName>Not amended.</filingPersonName>
      </item2>
      <item3>
        <fundsSource>Not amended.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>Not amended.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>As of the date of this Amendment, each of the Reporting Persons may be deemed to beneficially own, in the aggregate, 1,650,505 shares of Common Stock, consisting of (i) 1,479,450 shares of Common Stock held in the Accounts and (ii) warrants exercisable for an aggregate of 171,055 shares of Common Stock held in the Accounts. The aggregate holdings reported herein represent approximately 5.9% of the outstanding Common Stock, calculated in accordance with Rule 13d-3 of the Securities Exchange Act based on (x) 27,903,326 shares of Common Stock outstanding as of September 14, 2026, as reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 15, 2026, plus (y) 171,055 shares of Common Stock issuable upon exercise of warrants deemed beneficially owned by the Reporting Persons.</percentageOfClassSecurities>
        <numberOfShares>See rows (7) through (10) of the cover pages to this Amendment, which are incorporated herein by reference.</numberOfShares>
        <transactionDesc>On September 16, 2026, the Investment Manager sold 1,500 shares of Common Stock in an open-market transaction at a price of $0.2855 per share.
Except as set forth above, the Reporting Persons have not effected any other transactions in the Common Stock since September 4, 2026.</transactionDesc>
        <listOfShareholders>Not amended.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Not amended.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Not amended.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Lagoda Investment Management, L.P.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jason A. Ozone</signature>
          <title>Jason A. Ozone, Chief Financial Officer &amp; Chief Compliance Officer</title>
          <date>09/16/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Lagoda Investment Management, LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fatima Dickey</signature>
          <title>Fatima Dickey, Sole Member</title>
          <date>09/16/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Fatima Dickey</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Fatima Dickey</signature>
          <title>Fatima Dickey</title>
          <date>09/16/2026</date>
        </signatureDetails>
      </signaturePerson>
      <commentText>Not applicable.</commentText>
    </signatureInfo>
  </formData>
</edgarSubmission>
